Intestinal responses to xenobiotics

被引:30
作者
Carrière, V [1 ]
Chambaz, J [1 ]
Rousset, M [1 ]
机构
[1] Univ Paris 06, INSERM, U505, F-75006 Paris, France
关键词
enterocytes; Caco-2/TC7; clone; CYP3A4; CYP1A1; glucose metabolism;
D O I
10.1016/S0887-2333(01)00039-X
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The gastrointestinal tract represents the first barrier met by the exogenous compounds of food or orally delivered drugs. To be transferred to the whole body, drugs and xenobiotics have first to pass through the intestinal epithelium, where detoxification systems have to minimize the potential of damage from toxic xenobiotics. However, most studies on xenobiotic-metabolizing enzymes have focused on liver enzymes. Such a situation may be explained by the fact that this organ is the site of toxification/detoxification for both endogenous and exogenous compounds, and also because adequate in vitro hepatocytes models have been available for a long time. By contrast, normal cellular models for the in vitro study of the intestinal processes of biotransformation still remain difficult to obtain. In the present report we will thus focus on the most commonly used models, which are Caco-2 cells and their derivative clones, and we will report recent procedures that allow the isolation of normal enterocytes which maintain their functions and integrity for several hours or even several days. Their respective performance arid advantages for the study of the induction of the drug-metabolizing enzymes will be discussed. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:373 / 378
页数:6
相关论文
共 38 条
[1]   Drug absorption studies of prodrug esters using the Caco-2 model: evaluation of ester hydrolysis and transepithelial transport [J].
Augustijns, P ;
Annaert, P ;
Heylen, P ;
Van den Mooter, G ;
Kinget, R .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 166 (01) :45-53
[2]   Primary porcine enterocyte and hepatocyte cultures to study drug oxidation reactions [J].
Bader, A ;
Hansen, T ;
Kirchner, G ;
Allmeling, C ;
Haverich, A ;
Borlak, JT .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 (02) :331-342
[3]   SUBSTRATE-SPECIFICITY AND SOME PROPERTIES OF PHENOL SULFOTRANSFERASE FROM HUMAN INTESTINAL CACO-2 CELLS [J].
BARANCZYKKUZMA, A ;
GARREN, JA ;
HIDALGO, IJ ;
BORCHARDT, RT .
LIFE SCIENCES, 1991, 49 (16) :1197-1206
[4]   EVIDENCE FOR GLUCURONIDE CONJUGATION OF PARA-NITROPHENOL IN THE CACO-2 CELL MODEL [J].
BJORGE, S ;
HAMELEHLE, KL ;
HOMAN, R ;
ROSE, SE ;
TURLUCK, DA ;
WRIGHT, DS .
PHARMACEUTICAL RESEARCH, 1991, 8 (11) :1441-1443
[5]  
BOULENC X, 1992, J PHARMACOL EXP THER, V263, P1471
[6]   CHARACTERIZATION OF A NEWLY ISOLATED CACO-2 CLONE (TC-7), AS A MODEL OF TRANSPORT PROCESSES AND BIOTRANSFORMATION OF DRUGS [J].
CARO, I ;
BOULENC, X ;
ROUSSET, M ;
MEUNIER, V ;
BOURRIE, M ;
JULIAN, B ;
JOYEUX, H ;
ROGUES, C ;
BERGER, Y ;
ZWEIBAUM, A ;
FABRE, G .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 116 (02) :147-158
[7]   Regulation of sucrase-isomaltase and hexose transporters in Caco-2 cells: A role for cytochrome P-4501A1? [J].
Carriere, V ;
Barbat, A ;
Rousset, M ;
BrotLaroche, E ;
Dussaulx, E ;
Cambier, D ;
DeWaziers, I ;
Beaune, P ;
Zweibaum, A .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1996, 270 (06) :G976-G986
[8]   EXPRESSION OF CYTOCHROME-P-450 3A IN HT29-MTX CELLS AND CACO-2 CLONE TC7 [J].
CARRIERE, V ;
LESUFFLEUR, T ;
BARBAT, A ;
ROUSSET, M ;
DUSSAULX, E ;
COSTET, P ;
DEWAZIERS, I ;
BEAUNE, P ;
ZWEIBAUM, A .
FEBS LETTERS, 1994, 355 (03) :247-250
[9]   Hypoxia and CYP1A1 induction-dependent regulation of proteins involved in glucose utilization in Caco-2 cells [J].
Carrière, V ;
Rodolosse, A ;
Lacasa, M ;
Cambier, D ;
Zweibaum, A ;
Rousset, M .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1998, 274 (06) :G1101-G1108
[10]  
CHANTRET I, 1994, J CELL SCI, V107, P213